iGH was established to support the assessment, acceleration, introduction and execution of global health innovations. We are driven by the belief that innovation, and innovative partnerships, can significantly improve health outcomes in low-income countries.
Innovative approaches to product development and introduction in low-income settings are inherently risky and require careful analysis and planning. iGH brings substantial experience in product development and delivery combined with analytical rigor to help clients make sound choices and optimize health impact.
Our team provides support for investment choices such as market analysis, supply and demand forecasting, pricing analysis and state-of-the-art market research and expert input techniques. We have first-hand knowledge and key relationships with the most important stakeholders in the world of global health.
We support client partnering and business development needs to ensure that the most important innovations in global health reach those in most need, backed by strong collaborative partnerships that will endure.